Our unique partnership with OICR offers Canadian researchers unprecedented access to commercialization resources and infrastructure to de-risk and validate new disease-modifying therapies for oncology. Pre-proposals now open until August 31.
In 2 minutes find out how we are successfully bridging the commercialization gap between academia and industry to translate research discoveries into new drug therapies for patients.
CDRD & IRICoR have teamed up to fund new projects in cancer and Parkinson’s.
CDRD is a proud sponsor and regional host of the Sanofi Biogenius Canada competition for high school students. It’s critical that we all support science education!
Congrats to Nathan Kuene for winning the CDRD Commercialization Award and placing 2nd in the overall regional competition.
Results from CDRD project with UBC researcher Dr. Kelly McNagny published in Breast Cancer Research.
Inhibiting podocalyxin, a specific protein associated with aggressive, hard-to-treat tumours slows down their ability to spread to other sites in the body.
Find out how CDRD and CDRD Ventures can now support Canadian Health Sciences Companies…..
The award-winning UBC Pharmaceutical Sciences Building is home to The Centre for Drug Research and Development and CDRD Ventures Inc.
CDRD BY THE NUMBERS:
Our latest Trainee Spotlight focuses on Dr. Jayakumar Surendradoss, our current Post-Doctoral Fellow in our Pharmacology/Toxicology Division. Click here to find out more about him.
The Centre for Drug Research and Development (CDRD) is Canada’s fully-integrated national drug development and commercialization centre, providing expertise and infrastructure to enable researchers from leading health research institutions to advance promising early-stage drug candidates. Our mandate is to de-risk discoveries stemming from publicly-funded health research and transform them into viable investment opportunities for the private sector — thus successfully bridging the commercialization gap between academia and industry, and translating research discoveries into new therapies for patients. Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).